In IC/BPS patients, Shen et al. [25] determined that urine levels of IL4 significantly decreased 4 weeks after treatment with extracorporeal shock wave therapy compared to placebo. This evidence concerns the gene IL4 and Bartsocas-Papas syndrome 1.